PROZOLE-P TAB is a highly effective combination therapy comprising Pantoprazole, a proton pump inhibitor (PPI), and Domperidone, a peripheral dopamine receptor antagonist with strong prokinetic and antiemetic properties. This tablet formulation is designed to relieve symptoms of gastrointestinal disorders like GERD, acid reflux, gastritis, and related motility dysfunctions.

Pantoprazole, the core acid-reducing agent in the formulation, works by inhibiting the proton pumps (H+/K+ ATPase enzymes) in the gastric parietal cells, thereby significantly decreasing acid secretion at the source. Its irreversible action provides long-lasting acid suppression, essential in healing inflamed esophageal tissues, managing peptic ulcers, and preventing the recurrence of acid-related damage.

Domperidone supports Pantoprazole's acid-suppressing action by facilitating gastric emptying and enhancing gastrointestinal motility. It acts peripherally on dopamine D2 receptors without significantly crossing the blood-brain barrier, minimizing central nervous system side effects. This makes it especially effective in managing symptoms like nausea, vomiting, early satiety, and bloating associated with delayed gastric emptying.

PROZOLE-P TAB is commonly indicated for conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, chronic gastritis, functional dyspepsia, and indigestion due to hyperacidity or gastric stasis. It is also beneficial in managing reflux-related respiratory symptoms like cough or laryngitis that result from acid regurgitation.

The dual mechanism of action ensures rapid relief from acute symptoms while offering long-term protection and mucosal healing. Pantoprazole’s enteric-coated component is typically activated in the intestine, ensuring stability and effective absorption, while Domperidone provides prompt symptom control by acting soon after ingestion. Taken before meals, PROZOLE-P TAB maximizes absorption and clinical efficacy.

Patients generally tolerate PROZOLE-P TAB well. Adverse effects, if any, are usually mild and transient, including headache, flatulence, dry mouth, or abdominal discomfort. However, with prolonged use, especially at higher doses, monitoring is recommended for serum magnesium levels, vitamin B12 levels, and renal function. Bluepill Express ensures that each tablet is manufactured in compliance with WHO-GMP, ISO, and other international pharmaceutical guidelines to ensure consistent quality and global compatibility.

Our manufacturing facilities use state-of-the-art technology for granulation, compression, and enteric coating processes. All batches of PROZOLE-P TAB undergo stringent quality checks for disintegration time, content uniformity, stability, dissolution profile, and microbial limits. Documentation support including Certificate of Analysis (COA), stability data, method validation, and regulatory filing assistance is available for all partners.

As a trusted name in pharmaceutical manufacturing, Bluepill Express exports PROZOLE-P TAB to over 140 countries worldwide. Our packaging options include blister packs, alu-alu formats, and bulk supply solutions to cater to hospitals, pharmacies, and institutional tenders. We also offer customized branding and private labeling services for businesses looking to expand their product line in gastroenterology.